| Legislator | Pty | St | Total |
|---|---|---|---|
| Brett Guthrie | R | KY | $100 |
| Bill Cassidy | R | LA | $100 |
| Payee | Count | Total |
|---|---|---|
| DR. RICHARD PAN FOR CONGRESS | 1 | $500 |
| DR. BILL CASSIDY FOR US SENATE | 1 | $100 |
| BRETT GUTHRIE FOR CONGRESS | 1 | $100 |
| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 2nd Quarter - Report |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ARPA-H GO | $12,500 | |
| 2026 2nd Quarter - Report |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ACT FOR ULTRA RARE | $37,500 | |
| 2026 2nd Quarter - Report |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ENDEAVOR BIOMEDICINES | $51,000 | |
| 2026 2nd Quarter - Report |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ELEMENT BIOSCIENCES | $44,000 | |
| 2026 1st Quarter - Report |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ARPA-H GO | $7,500 | |
| 2026 Registration |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ARPA-H GO | — | |
| 2026 1st Quarter - Termination |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ULTRAGENYX PHARMACEUTICAL | — | |
| 2026 1st Quarter - Report |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ACT FOR ULTRA RARE | $37,500 | |
| 2026 1st Quarter - Report |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ELEMENT BIOSCIENCES | $39,000 | |
| 2026 Registration |
AVIVA STRATEGIES (FKA MGB CONSULTING) | ACT FOR ULTRA RARE | — |
| Recipient / Honoree | Legislator | Payee / Committee | Date | Amount |
|---|---|---|---|---|
| Dr. Richard Pan | — | DR. RICHARD PAN FOR CONGRESS | Dec 12, 2025 | $500 |
| Brett Guthrie | Brett Guthrie (R, KY) | BRETT GUTHRIE FOR CONGRESS | Apr 24, 2025 | $100 |
| Bill Cassidy | Bill Cassidy (R, LA) | DR. BILL CASSIDY FOR US SENATE | Apr 24, 2025 | $100 |